[144] Clearwater Analytics Holdings, Inc. SEC Filing

Rhea-AI Filing Summary

CWAN insider James Cox has filed a Form 144 notice to sell 18,700 shares of common stock. The planned sale, with an aggregate market value of 432,905.00, is expected around 02/17/2026 through Morgan Stanley Smith Barney on the NYSE.

The shares to be sold come from a mix of recent equity awards. Cox acquired 13,700 shares on 02/17/2026 via a cash exercise of stock options and 5,000 shares on 02/21/2023 from restricted stock units. The filing also lists multiple prior sales over the past three months, including 63,709 shares of common stock sold on 01/01/2026 for gross proceeds of 1,534,909.08, some under a Rule 10b5-1 trading plan.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	18700	432905.00	288154032	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2026	Exercise of Stock Options	Issuer			13700	02/17/2026	Cash
Common	02/21/2023	Restricted Stock Units	Issuer			5000	02/21/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	01/15/2026	18700	451440.48
JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	01/01/2026	63709	1534909.08
JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	12/31/2025	5859	141105.81
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	12/17/2025	7425	163350.00
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	12/15/2025	11275	241377.43
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	11/25/2025	29700	653400.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CWAN Form 144 filing by James Cox disclose?

The Form 144 discloses James Cox’s intent to sell 18,700 CWAN common shares. The planned sale, valued at 432,905.00, is expected around 02/17/2026 through Morgan Stanley Smith Barney on the NYSE, and follows multiple prior sales in recent months.

How many CWAN shares is James Cox planning to sell under this Form 144?

James Cox plans to sell 18,700 shares of CWAN common stock. The filing lists an aggregate market value of 432,905.00 for this block, to be sold through Morgan Stanley Smith Barney, with an approximate sale date of 02/17/2026 on the NYSE.

How did James Cox acquire the CWAN shares covered by this Form 144?

The shares come from stock option exercises and restricted stock units. Cox acquired 13,700 common shares on 02/17/2026 via a cash stock option exercise and 5,000 shares on 02/21/2023 from restricted stock units originally granted by the issuer.

What prior CWAN stock sales by James Cox are listed in the Form 144?

The notice lists several CWAN sales over the past three months. These include 63,709 shares sold on 01/01/2026 for 1,534,909.08 and additional transactions on 12/31/2025, 12/17/2025, 12/15/2025, and 11/25/2025, some under a 10b5-1 plan.

Is James Cox using a Rule 10b5-1 trading plan for CWAN share sales?

Yes, some sales are identified as part of a Rule 10b5-1 sales plan. The filing references a “10b5-1 Sales Plan for JAMES COX” for several recent common stock transactions, indicating certain trades were prearranged under a written trading plan.

Which broker is handling James Cox’s planned CWAN share sale?

Morgan Stanley Smith Barney LLC Executive Financial Services is the listed broker. The Form 144 states the 18,700 CWAN common shares, with an aggregate market value of 432,905.00, are expected to be sold on the NYSE through this broker at New York Plaza.